logo
Plus   Neg
Share
Email

Thermo Fisher Adds Two New COVID-19 Antibody Tests To Its Portfolio - Quick Facts

Thermo Fisher Scientific Inc. (TMO) announced two SARS-CoV-2 antibody tests: OmniPATH COVID-19 Total Antibody ELISA test, and the EliA SARS-CoV-2-Sp1 IgG test. These new tests are for detecting COVID-19 antibodies.

The company said its OmniPATH COVID-19 Total Antibody ELISA test, developed in conjunction with the Mayo Clinic and WuXi Diagnostics, has been previously granted Emergency Use Authorization from the FDA for qualitative detection of total antibodies to SARS-CoV-2, including immunoglobulin M (IgM), immunoglobulin A (IgA) and immunoglobulin G (IgG). The EliA SARS-CoV-2-Sp1 IgG test is commercially available in accordance with the FDA's, Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised).

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
An advisory panel to the Centers for Disease Control and Prevention has proposed that healthcare workers and long-term facility residents be given the first doses of the COVID-19 vaccine when it is cleared for public use in the U.S. The CDC's Advisory Committee on Immunization Practices met virtually on Tuesday and panel passed the proposal 13-1. Online activity on the two days in the Thanksgiving weekend, Black Friday and Saturday, saw tremendous growth, according to the National Retail Federation's Annual Thanksgiving Weekend Consumer Survey, conducted by Prosper Insights & Analytics. Online-only shoppers increased 44 percent to 95.7 million for the entire weekend. Professional services provider Jacobs Engineering Group Inc. announced the launch of One Million Lives, a free mental health check-in tool, to help users understand their current state of mind and seek mental health and wellbeing solutions. The new tool may help people affected by the struggles of ongoing lockdowns during worsening coronavirus crisis.
Follow RTT